27/05/2026
Last week, Signe Velina, PMPC Center of Excellence project WP3 lead, participated in the organised by the BBMRI-ERIC community and partners — an important platform bringing together experts in biobanking, precision medicine, ethics, and healthcare innovation across Europe.
This year’s European Biobank Week congress placed a strong focus, both in dedicated sessions and pre-congress workshops, on pediatric biobanking, Special sessions and workshops focused on:
🔹 informed consent in pediatric biobanking and how it differs from adult consent,
🔹 age-appropriate communication with children and families,
🔹 legal and ethical aspects of consent,
🔹 involving patient representatives in the development of consent forms.
Discussions highlighted that approaches across Europe still differ, while the BBMRI-ERIC community is exploring opportunities for more harmonised recommendations in the future.
The congress also explored how biobanks can strengthen public engagement through initiatives such as science days and open-door events for researchers, clinicians, patients, families, and the wider public. Another important topic was how to manage and communicate incidental findings discovered during research.
Beyond biobanking itself, keynote speakers provided a broader healthcare perspective — including how climate change is influencing the spread of infectious diseases in Europe, and how upcoming European biotechnology initiatives could accelerate clinical research and innovation.
Importantly for PMPC Center of Excellence, several sessions demonstrated how biobanks contribute to the development of oncology biomarkers, supporting not only diagnostics but also disease prognosis and future treatment strategies.
These discussions strongly resonate with PMPC Center of Excellence mission: building an integrated research infrastructure that combines a biobank, clinical trial capabilities, and advanced genetic technologies to advance pediatric precision medicine.
Apvārsnis EU Latvijas Nacionālais kontaktpunkts - HE NCP LV EU Science & Innovation